The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults. Journavx ...

The US FDA has approved the first clinical trials for pig kidney transplants in humans. According to the organisation, two ...

The U.S. Senate has confirmed about half of President Donald Trump's picks for his cabinet so far. Here are Trump's choices for some key posts. PETE ...

Valneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s MHRA, allowing the single-dose vaccine to be made ...

"Yo-yo" dieting --- repeatedly losing and gaining weight -- can significantly increase risk of kidney disease among people ...

US FDA has approved its first ever non-opioid painkiller called suzetrigine. Experts believe it will prevent addiction problems unlike existing opioids.

The FDA has approved the sBLA for once every 4 weeks lecanemab-irmb (Leqembi®) intravenous maintenance dosing.

NOVATO, Calif. - Ultragenyx Pharmaceutical Inc. (NASDAQ: NASDAQ:RARE), a $4.08 billion market cap biotechnology company with 27% revenue growth in the past year, today unveiled new data indicating ...

The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...

High-dose treatment with the therapy was found to cause a 3.3% overall improvement in left ventricular ejection fraction.

State leaders are reviving talk of importing prescription drugs from Canada, even as US drugmakers and health-care attorneys ...